• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肉瘤中的离子通道:病理生理学和治疗选择。

Ion channels in sarcoma: pathophysiology and treatment options.

机构信息

Abteilung für Plastische, Hand- und Wiederherstellungschirurgie, Universitätsklinikum Regensburg, Regensburg, Germany.

Lehrstuhl für Molekulare und Zelluläre Anatomie, Universität Regensburg, 93053, Regensburg, Germany.

出版信息

Pflugers Arch. 2019 Sep;471(9):1163-1171. doi: 10.1007/s00424-019-02299-8. Epub 2019 Aug 3.

DOI:10.1007/s00424-019-02299-8
PMID:31377822
Abstract

Sarcomas are characterized by aggressive growth and a high metastasis potentially leading in most cases to a lethal outcome. These malignant tumors of the connective tissue have a high heterogeneity with numerous genetic mutations resulting in more than 100 types of sarcoma that can be grouped into two main kinds: soft tissue sarcoma and bone sarcoma. Sarcomas are often diagnosed at late disease stage, whereas a guaranteed diagnosis of the sarcoma type is fundamental for successful therapy. However, there is no appropriate therapy available. Therefore, the need for new therapies, which prolong survival and improve quality of life, is high. In the last two decades, the role of ion channels in cancer has emerged. Ion channels seem to be an ideal target for anti-tumor therapies. However, different cancer types have their own altered ion channel pattern, and the knowledge about the tumor-associated ion channel expression is fundamental. Here, we focus on the role of different ion channels in sarcoma, their pathophysiology, and possible treatment options.

摘要

肉瘤的特征是侵袭性生长和高转移率,这可能导致大多数情况下的致命后果。这些结缔组织的恶性肿瘤具有高度异质性,存在许多基因突变,导致超过 100 种肉瘤类型,可以分为两种主要类型:软组织肉瘤和骨肉瘤。肉瘤通常在疾病晚期才被诊断出来,而保证肉瘤类型的明确诊断对于成功治疗至关重要。然而,目前尚无合适的治疗方法。因此,需要新的治疗方法来延长生存时间并提高生活质量。在过去的二十年中,离子通道在癌症中的作用已经显现出来。离子通道似乎是抗肿瘤治疗的理想靶点。然而,不同的癌症类型有其自身改变的离子通道模式,了解与肿瘤相关的离子通道表达是基础。在这里,我们重点介绍不同离子通道在肉瘤中的作用、它们的病理生理学以及可能的治疗选择。

相似文献

1
Ion channels in sarcoma: pathophysiology and treatment options.肉瘤中的离子通道:病理生理学和治疗选择。
Pflugers Arch. 2019 Sep;471(9):1163-1171. doi: 10.1007/s00424-019-02299-8. Epub 2019 Aug 3.
2
Expression of E-cadherin in bone and soft tissue sarcomas: a possible role in epithelial differentiation.E-钙黏蛋白在骨与软组织肉瘤中的表达:在上皮分化中的可能作用。
Hum Pathol. 1999 Nov;30(11):1344-9. doi: 10.1016/s0046-8177(99)90066-7.
3
LHRH receptor expression in sarcomas of bone and soft tissue.促黄体激素释放激素受体在骨与软组织肉瘤中的表达。
Horm Mol Biol Clin Investig. 2016 Nov 1;28(2):105-111. doi: 10.1515/hmbci-2016-0001.
4
L-type amino acid transporter-1 and CD98 expression in bone and soft tissue tumors.L型氨基酸转运体-1与CD98在骨与软组织肿瘤中的表达
Pathol Int. 2015 Sep;65(9):460-7. doi: 10.1111/pin.12323. Epub 2015 Jul 1.
5
Expression of neural cell adhesion molecules and neurofilament protein isoforms in Ewing's sarcoma of bone and soft tissue sarcomas other than rhabdomyosarcoma.神经细胞黏附分子和神经丝蛋白异构体在骨尤文肉瘤及横纹肌肉瘤以外的软组织肉瘤中的表达。
Hum Pathol. 1999 Oct;30(10):1207-12. doi: 10.1016/s0046-8177(99)90039-4.
6
High expression of neuropeptide Y1 receptors in ewing sarcoma tumors.神经肽Y1受体在尤因肉瘤肿瘤中的高表达。
Clin Cancer Res. 2008 Aug 15;14(16):5043-9. doi: 10.1158/1078-0432.CCR-07-4551.
7
MDR1 gene expression: evaluation of its use as a molecular marker for prognosis and chemotherapy of bone and soft tissue sarcomas.多药耐药基因1(MDR1)表达:评估其作为骨肉瘤和软组织肉瘤预后及化疗分子标志物的应用价值。
Eur J Cancer. 1996 Jan;32A(1):86-92. doi: 10.1016/0959-8049(95)00478-5.
8
Down-regulated E-cadherin expression is associated with poor five-year overall survival in bone and soft tissue sarcoma: results of a meta-analysis.E-钙黏蛋白表达下调与骨肉瘤和软组织肉瘤的五年总生存率低相关:一项荟萃分析的结果
PLoS One. 2015 Mar 30;10(3):e0121448. doi: 10.1371/journal.pone.0121448. eCollection 2015.
9
Grb2-associated binding protein-1 as a biomarker in bone and soft tissue sarcomas.Grb2 相关结合蛋白 1 作为骨与软组织肉瘤的生物标志物。
Pathology. 2019 Oct;51(6):610-614. doi: 10.1016/j.pathol.2019.05.003. Epub 2019 Aug 20.
10
Telomerase activity in soft-tissue and bone sarcomas.软组织和骨肉瘤中的端粒酶活性
Clin Cancer Res. 2000 Dec;6(12):4776-81.

引用本文的文献

1
Electrical stimulation directs articular chondrocyte and chondrosarcoma migration in a 3D collagen matrix.电刺激引导关节软骨细胞和软骨肉瘤在三维胶原基质中迁移。
Biochem Biophys Res Commun. 2025 Jul 12;770:151998. doi: 10.1016/j.bbrc.2025.151998. Epub 2025 May 10.
2
Integrative profiling analysis reveals prognostic significance, molecular characteristics, and tumor immunity of angiogenesis-related genes in soft tissue sarcoma.整合分析揭示了软组织肉瘤中血管生成相关基因的预后意义、分子特征和肿瘤免疫。
Front Immunol. 2023 Jun 12;14:1178436. doi: 10.3389/fimmu.2023.1178436. eCollection 2023.
3
The development of a novel signature based on the mA RNA methylation regulator-related ceRNA network to predict prognosis and therapy response in sarcomas.

本文引用的文献

1
Scorpion toxins targeting Kv1.3 channels: insights into immunosuppression.靶向Kv1.3通道的蝎毒素:对免疫抑制的见解。
J Venom Anim Toxins Incl Trop Dis. 2019 Apr 15;25:e148118. doi: 10.1590/1678-9199-JVATITD-1481-18. eCollection 2019.
2
miRNA deregulation targets specific pathways in leiomyosarcoma development: an in silico analysis.miRNA 失调靶向平滑肌肉瘤发展中的特定途径:一项计算机分析。
J Transl Med. 2019 May 14;17(1):153. doi: 10.1186/s12967-019-1907-2.
3
Surgery in reference centers improves survival of sarcoma patients: a nationwide study.
基于mA RNA甲基化调节因子相关ceRNA网络开发一种新型特征以预测肉瘤的预后和治疗反应。
Front Genet. 2022 Oct 12;13:894080. doi: 10.3389/fgene.2022.894080. eCollection 2022.
4
Open channel block of Kv1.5 channels by HMQ1611.HMQ1611对Kv1.5通道的开放通道阻断作用
Front Pharmacol. 2022 Sep 16;13:965086. doi: 10.3389/fphar.2022.965086. eCollection 2022.
5
Identification of Iron Metabolism-Related Gene Signatures for Predicting the Prognosis of Patients With Sarcomas.用于预测肉瘤患者预后的铁代谢相关基因特征的鉴定
Front Oncol. 2021 Jan 7;10:599816. doi: 10.3389/fonc.2020.599816. eCollection 2020.
6
TRPA1 Expression in Synovial Sarcoma May Support Neural Origin.瞬时受体电位锚蛋白1在滑膜肉瘤中的表达可能支持其神经起源。
Biomolecules. 2020 Oct 15;10(10):1446. doi: 10.3390/biom10101446.
参考中心的手术可提高肉瘤患者的生存率:一项全国性研究。
Ann Oncol. 2019 Jul 1;30(7):1143-1153. doi: 10.1093/annonc/mdz124.
4
PIEZO1 Channel Is a Potential Regulator of Synovial Sarcoma Cell-Viability.PIEZO1 通道是滑膜肉瘤细胞活力的潜在调节因子。
Int J Mol Sci. 2018 May 14;19(5):1452. doi: 10.3390/ijms19051452.
5
Ion Channels in Cancer: Are Cancer Hallmarks Oncochannelopathies?离子通道与癌症:癌症特征性病变是离子通道病吗?
Physiol Rev. 2018 Apr 1;98(2):559-621. doi: 10.1152/physrev.00044.2016.
6
Na entry through heteromeric TRPC4/C1 channels mediates (-)Englerin A-induced cytotoxicity in synovial sarcoma cells.异源 TRPC4/C1 通道的内流介导了 (-)Englerin A 诱导的滑膜肉瘤细胞的细胞毒性。
Sci Rep. 2017 Dec 5;7(1):16988. doi: 10.1038/s41598-017-17303-3.
7
Improved survival using specialized multidisciplinary board in sarcoma patients.在肉瘤患者中使用专门的多学科委员会可提高生存率。
Ann Oncol. 2017 Nov 1;28(11):2852-2859. doi: 10.1093/annonc/mdx484.
8
The Function of the Novel Mechanical Activated Ion Channel Piezo1 in the Human Osteosarcoma Cells.新型机械激活离子通道 Piezo1 在人骨肉瘤细胞中的功能。
Med Sci Monit. 2017 Oct 24;23:5070-5082. doi: 10.12659/msm.906959.
9
Recent advances in the diagnosis of soft tissue tumours.软组织肿瘤诊断的最新进展。
Pathology. 2018 Jan;50(1):37-48. doi: 10.1016/j.pathol.2017.07.007. Epub 2017 Sep 23.
10
Touch, Tension, and Transduction - The Function and Regulation of Piezo Ion Channels.触觉、张力与转导——Piezo离子通道的功能与调控
Trends Biochem Sci. 2017 Jan;42(1):57-71. doi: 10.1016/j.tibs.2016.09.004. Epub 2016 Oct 12.